First MNC Drug Retailer To Enter China Restructures Operation
This article was originally published in PharmAsia News
Medicine Shoppe, the first MNC drug retailer to enter China five years ago, is restructuring in response to difficulty in developing the market. It is closing down its eastern branch, and will be focusing on the country's eastern and southern regions this year. The company has adopted a franchise model to accelerate its market entry but faces shortcomings amidst intense competition. Medicine Shoppe plans to step up brand marketing and raise standards for new franchisees. It will now concentrate on penetrating deeper into the market it currently operates in rather than expanding into new cities. (Click here for more - Chinese Language
You may also be interested in...
Procter & Gamble, through its UK wellness subsidiary Nature's Best, is on-trend with new vegan vitamin D3 and iron supplements. Nature's Best has also launched three other vitamin D3 products in the country, as well as an ashwagandha supplement.
The MHRA has updated its guidance on regulatory flexibilities for medical devices and medicinal products resulting from COVID-19 to highlight how its approach differs from the EU.
The Swiss company is planning a US trial of CBSO, the first transcatheter septal occluder with a bioresorbable, metal-free frame.